These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33575286)

  • 1. Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study.
    Wang K; Lu D; Liu Y; Li W; Zhuang L; Ma Z; Xie Q; Pan B; Wu Y; Chen J; Lin L; Feng X; Wei Q; Wei X; Xie H; Wang Z; Zheng S; Xu X
    Hepatobiliary Surg Nutr; 2021 Jan; 10(1):9-19. PubMed ID: 33575286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
    Mazilescu LI; Kotha S; Ghanekar A; Lilly L; Reichman TW; Galvin Z; Cattral MS; Bhat M; McGilvray ID; Sapisochin G; Sayed B; Selzner M; Selzner N
    Transplant Direct; 2021 Aug; 7(8):e727. PubMed ID: 34291149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts.
    Croome KP; Wall W; Quan D; Vangala S; McAlister V; Marotta P; Hernandez-Alejandro R
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):372-6. PubMed ID: 22893463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
    Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Yang L; Xin EY; Liao B; Lai LJ; Han M; Wang XP; Ju WQ; Wang DP; Guo ZY; He XS
    Transplant Proc; 2017; 49(6):1357-1363. PubMed ID: 28736007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation.
    Yang M; Khan AR; Lu D; Wei X; Shu W; Xu C; Pan B; Zhou Z; Wang R; Wei Q; Cen B; Cai J; Zheng S; Xu X
    Front Med (Lausanne); 2022; 9():772048. PubMed ID: 35308496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death.
    Xie H; Zhang L; Guo D; Yang Z; Zhu H; Zhou K; Feng X; Wei Q; Xu X; Song P; Wen X; Li J; Liu J; Zheng S
    Transplantation; 2020 Jan; 104(1):79-89. PubMed ID: 31283675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C-positive recipients.
    Martini S; Tandoi F; Terzi di Bergamo L; Strona S; Lavezzo B; Sacco M; Maione F; Gonella F; Strignano P; Dell Olio D; Salizzoni M; Saracco GM; Romagnoli R
    Liver Transpl; 2017 Jul; 23(7):915-924. PubMed ID: 28422425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of early liver dysfunction after liver transplantation using grafts from donation after citizen death donors.
    He YB; Sun JS; Wang ZP; Yao G; Bai L; Li T; Zhao JM
    Transpl Immunol; 2022 Apr; 71():101525. PubMed ID: 34990790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation.
    Selten JW; Verhoeven CJ; Heedfeld V; Roest HP; de Jonge J; Pirenne J; van Pelt J; Ijzermans JNM; Monbaliu D; van der Laan LJW
    Liver Transpl; 2017 Jul; 23(7):946-956. PubMed ID: 28388830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram for prediction of early allograft dysfunction in living donor liver transplantation.
    Ko YC; Tsai HI; Lee CW; Lin JR; Lee WC; Yu HP
    Medicine (Baltimore); 2020 Oct; 99(42):e22749. PubMed ID: 33080739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival.
    Lee DD; Singh A; Burns JM; Perry DK; Nguyen JH; Taner CB
    Liver Transpl; 2014 Dec; 20(12):1447-53. PubMed ID: 25179581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements.
    Lee DD; Croome KP; Shalev JA; Musto KR; Sharma M; Keaveny AP; Taner CB
    Ann Hepatol; 2016; 15(1):53-60. PubMed ID: 26626641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postreperfusion Liver Biopsy as Predictor of Early Graft Dysfunction and Survival After Orthotopic Liver Transplantation.
    Fuentes-Valenzuela E; Tejedor-Tejada J; García-Pajares F; Rubiales BM; Nájera-Muñoz R; Maroto-Martín C; Sánchez-Delgado L; Alonso-Martín C; Álvarez CA; Sánchez-Antolín G
    J Clin Exp Hepatol; 2022; 12(4):1133-1141. PubMed ID: 35814514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.
    Agopian VG; Markovic D; Klintmalm GB; Saracino G; Chapman WC; Vachharajani N; Florman SS; Tabrizian P; Haydel B; Nasralla D; Friend PJ; Boteon YL; Ploeg R; Harlander-Locke MP; Xia V; DiNorcia J; Kaldas FM; Yersiz H; Farmer DG; Busuttil RW
    J Hepatol; 2021 Apr; 74(4):881-892. PubMed ID: 32976864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction.
    Bastos-Neves D; Salvalaggio PRO; Almeida MD
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):423-429. PubMed ID: 30853253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
    Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
    J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.
    Thomsen KL; Robertson FP; Holland-Fischer P; Davidson BR; Mookerjee RP; Møller HJ; Jalan R; Grønbæk H
    J Clin Exp Hepatol; 2019; 9(3):302-311. PubMed ID: 31360022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.